Clinical trial
A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers
NCT00155558 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00155558 |
|---|---|
| Title | A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers |
| Official title | A Phase I Trial of HDFL48(Weekly 48-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin) in Recurrent or Metastatic Colorectal Cancers |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent or Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | 5-Fluorouracil, Leucovorin |
| Enrollment | 16 |
| Start date | Mar 1, 2001 |
| Completion | Dec 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 25, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: